Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Evaluation of the most common tick-borne diseases found in the United States, including Lyme disease, human monocytic and granulocytic ehrlichiosis, and babesiosis
Evaluation of patients with a history of, or suspected, tick exposure who are presenting with fever, myalgia, headache, nausea, and other nonspecific symptoms
Seroepidemiological surveys of the prevalence of the infection in certain populations
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
EHRC | Ehrlichia Chaffeensis (HME) Ab, IgG | Yes | Yes |
ANAP | Anaplasma phagocytophilum Ab, IgG,S | Yes | Yes |
BABG | Babesia microti IgG Ab, S | Yes | Yes |
LYME | Lyme Disease Serology, S | Yes | Yes |
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
LYWB | Lyme Disease Ab, Immunoblot, S | Yes | No |
If Lyme disease screen is positive or equivocal, then Lyme disease antibody confirmation will be performed at an additional charge.
See Acute Tick-Borne Disease Testing Algorithm in Special Instructions.
EHRC, ANAP, BABG: Immunofluorescence Assay (IFA)
LYME: Enzyme-Linked Immunosorbent Assay (ELISA)